Skip to main content

and
  1. No Access

    Article

    Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study

    In France, around 25% of the estimated number of people living with HIV are migrants, of whom three quarters are from sub-Saharan Africa (SSA). Our objective was to determine factors associated with virologica...

    Jean-Médard Kankou, Olivier Bouchaud in Journal of Immigrant and Minority Health (2019)

  2. Article

    Open Access

    Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis

    The preferred regimen for HIV post-exposure prophylaxis (PEP) is based mainly on safety and tolerability because it is given to immunocompetent people without HIV infection for a limited time (28 days). The fr...

    Nadia Valin, Laurent Fonquernie, Anne Daguenel, Pauline Campa in BMC Infectious Diseases (2016)

  3. No Access

    Article

    Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome

    With DAAs still only being licensed for chronic HCV infection, the ongoing epidemic of acute hepatitis C (AHC) infection among MSM highlights the need to identify factors allowing for optimal HCV treatment out...

    Christoph Boesecke, Patrick Ingiliz, Thomas Reiberger, Hans-Jürgen Stellbrink in Infection (2016)

  4. Article

    Open Access

    Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

    Few studies have compared the impact of different antiretroviral regimens on residual immune activation and inflammation with discordant results. Aim of the study was to investigate the impact of various antir...

    Suhaib Hattab, Amelie Guihot, Marguerite Guiguet, Slim Fourati in BMC Infectious Diseases (2014)

  5. Article

    Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

    In this paper we evaluate the economic gains of a joint deployment of femtocells and macrocells for the provision of Long Term Evolution (LTE) mobile broadband services in urban environments. Frequency bands o...

    Valérie Martinez, Thi Dieu Ngan TA, Zahra Mokhtari, Marguerite Guiguet in Genome Biology (2013)

  6. Article

    Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

    In this paper we evaluate the economic gains of a joint deployment of femtocells and macrocells for the provision of Long Term Evolution (LTE) mobile broadband services in urban environments. Frequency bands o...

    Valérie Martinez, Thi Dieu Ngan TA, Zahra Mokhtari, Marguerite Guiguet in Genome Biology (2012)

  7. Article

    Open Access

    Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

    In HIV and hepatitis C virus (HCV) coinfected patients, the role of antiretroviral therapy (ART) on hepatic steatosis (HS) remains controversial.

    Valrie Martinez, Thi Dieu Ngan TA, Zahra Mokhtari, Marguerite Guiguet in BMC Research Notes (2012)

  8. No Access

    Article

    Postdischarge Adverse Drug Reactions in Primary Care Originating from Hospital Care in France

    Objective: To describe and estimate the incidence and preventability of postdischarge adverse drug reactions (ADRs) detected in primary care in France.

    Laurent Letrilliart, Thomas Hanslik, Michel Biour, Jean-Paul Fagot in Drug Safety (2001)

  9. No Access

    Article

    A critique of the use of DNA synthesis as a measure of the effect of mitogens on lymphocytes

    Marguerite Guiguet, Stephen Cooper in Bioscience Reports (1982)